NFASC
Basic information
Region (hg38): 1:204828651-205022822
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with central and peripheral motor dysfunction (Limited), mode of inheritance: AD
- neurodevelopmental disorder with central and peripheral motor dysfunction (Moderate), mode of inheritance: AR
- neurodevelopmental disorder with central and peripheral motor dysfunction (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodevelopmental disorder with central and peripheral motor dysfunction | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 28940097; 30124836; 30850329 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NFASC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 25 | 12 | 37 | |||
missense | 89 | 17 | 107 | |||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 3 | 5 | |||
non coding | 10 | |||||
Total | 1 | 1 | 93 | 47 | 16 |
Variants in NFASC
This is a list of pathogenic ClinVar variants found in the NFASC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-204926595-A-G | Neurodevelopmental disorder with central and peripheral motor dysfunction | Uncertain significance (May 14, 2020) | ||
1-204939306-C-T | Neurodevelopmental disorder with central and peripheral motor dysfunction | Uncertain significance (Jul 29, 2023) | ||
1-204944333-G-A | Likely benign (Jul 01, 2022) | |||
1-204944335-C-T | Inborn genetic diseases | Uncertain significance (Jul 25, 2023) | ||
1-204944337-C-T | Neurodevelopmental disorder with central and peripheral motor dysfunction • NFASC-related disorder | Uncertain significance (Jan 06, 2023) | ||
1-204944382-G-A | Inborn genetic diseases | Uncertain significance (Jul 06, 2022) | ||
1-204944400-A-G | Inborn genetic diseases | Likely benign (May 10, 2023) | ||
1-204952058-G-A | Inborn genetic diseases | Uncertain significance (Dec 22, 2023) | ||
1-204952071-A-G | Inborn genetic diseases | Uncertain significance (Mar 19, 2024) | ||
1-204952115-A-G | Uncertain significance (Mar 30, 2023) | |||
1-204952130-A-G | Neurodevelopmental disorder with central and peripheral motor dysfunction | Benign (Sep 05, 2021) | ||
1-204954224-C-T | Likely benign (Oct 01, 2022) | |||
1-204954235-C-T | Inborn genetic diseases | Uncertain significance (Nov 01, 2021) | ||
1-204954283-G-A | Inborn genetic diseases | Uncertain significance (Jun 30, 2023) | ||
1-204954297-C-A | Inborn genetic diseases | Uncertain significance (Feb 15, 2023) | ||
1-204954304-A-G | Inborn genetic diseases | Uncertain significance (Jun 01, 2023) | ||
1-204954348-A-G | Inborn genetic diseases | Uncertain significance (Jul 06, 2021) | ||
1-204954349-C-T | Uncertain significance (Nov 30, 2022) | |||
1-204954350-G-A | Likely benign (May 01, 2022) | |||
1-204954834-C-T | Inborn genetic diseases | Uncertain significance (Nov 12, 2021) | ||
1-204954892-C-T | Benign/Likely benign (Jul 01, 2024) | |||
1-204954911-G-A | NFASC-related disorder | Benign (Apr 26, 2018) | ||
1-204954942-A-G | Neurodevelopmental disorder with central and peripheral motor dysfunction | Uncertain significance (-) | ||
1-204957652-A-G | NFASC-related disorder | Likely benign (Sep 18, 2019) | ||
1-204957683-G-A | Inborn genetic diseases | Uncertain significance (Mar 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NFASC | protein_coding | protein_coding | ENST00000339876 | 28 | 194172 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.0000120 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.59 | 588 | 793 | 0.741 | 0.0000518 | 8068 |
Missense in Polyphen | 194 | 331.88 | 0.58455 | 3432 | ||
Synonymous | 0.216 | 328 | 333 | 0.985 | 0.0000246 | 2479 |
Loss of Function | 6.69 | 8 | 67.1 | 0.119 | 0.00000380 | 691 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.000240 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000928 | 0.0000924 |
European (Non-Finnish) | 0.0000534 | 0.0000527 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000341 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cell adhesion, ankyrin-binding protein which may be involved in neurite extension, axonal guidance, synaptogenesis, myelination and neuron-glial cell interactions. {ECO:0000250}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Developmental Biology;Neutrophil degranulation;Innate Immune System;Immune System;Neurofascin interactions;Interaction between L1 and Ankyrins;L1CAM interactions;Axon guidance
(Consensus)
Recessive Scores
- pRec
- 0.197
Intolerance Scores
- loftool
- 0.529
- rvis_EVS
- -1.8
- rvis_percentile_EVS
- 2.21
Haploinsufficiency Scores
- pHI
- 0.250
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.608
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.285
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nfasc
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein localization to paranode region of axon;axon guidance;peripheral nervous system development;transmission of nerve impulse;paranodal junction assembly;heterotypic cell-cell adhesion;myelination;neutrophil degranulation;clustering of voltage-gated sodium channels;synapse organization;protein localization to juxtaparanode region of axon;protein localization to plasma membrane
- Cellular component
- plasma membrane;focal adhesion;integral component of membrane;dendrite;paranodal junction;node of Ranvier;paranode region of axon;axon initial segment;myelin sheath;Schwann cell microvillus;ficolin-1-rich granule membrane
- Molecular function
- protein binding;protein domain specific binding;protein binding involved in heterotypic cell-cell adhesion